The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for SYD-101 (atropine sulfate) to slow the progression of ...
After rising to prominence during the COVID-19 pandemic, South African drugmaker Aspen Pharmacare has landed in the FDA's ...
Combination, if successful, would create a new publicly-listed eye care company combining Betaliq's EyeSol® water-free drug delivery technology for glaucoma with Eyenovia's Optejet® device platform Th ...
The proposed merger would create a new ophthalmic company that combines two FDA-approved technologies: Betaliq's EyeSol ® water-free drug delivery technology for use in glaucoma, and Eyenovia's ...
Verywell Health on MSN1d
What Causes Eye Miosis (Constricted Pupils)"Miosis" is a medical term that describes the constriction of the pupils. Learn its causes, symptoms, and how to treat it.
Tribune Content Agency on MSN8d
Color-changing eye drops: Are they safe?As the adage goes, the eyes are the windows to the soul. So what does it mean to wish yours were a different color?
Saline nasal sprays can also be used to flush out allergens and restore the natural moisture of the nasal lining. Steroid ...
The FDA has set a PDUFA target action date of October 23, 2025, for the low-dose atropine formulation.
New Drug Application (NDA) for LNZ100 for treatment of presbyopia on track for PDUFA target action date of August 8, 2025Upon FDA approval, ...
Toon Van Gorp, MD, PhD, discussed findings from the MIRASOL trial and the potential of mirvetuximab to redefine treatment ...
Figures from Police Scotland show that 2024 saw an 11 per cent drop ... to support drugs services. Former first minister Nicola Sturgeon famously admitted taking her “eye off the ball ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback